We are live on ! Find out more
Manulife (Manufacturers Life Insurance)

Manulife (Manufacturers Life Insurance) Portfolio holdings

AUM $116B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
-1.66%
1 Year Est. Return
+26.37%
3 Year Est. Return
+67.38%
5 Year Est. Return
+85.79%
10 Year Est. Return
+313.78%
AUM
$153B
AUM Growth
+$152B
Cap. Flow
+$1.16B
Cap. Flow %
0.76%
Top 10 Hldgs %
30.76%
Holding
3,267
New
155
Increased
738
Reduced
2,125
Closed
210

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$322M
2
AMZN icon
Amazon
AMZN
+$312M
3
ENB icon
Enbridge
ENB
+$248M
4
NEE icon
NextEra Energy
NEE
+$226M
5
VWO icon
Vanguard FTSE Emerging Markets ETF
VWO
+$211M

Top Sells

Rank Stock Value
1
VO icon
Vanguard Morningstar Mid-Cap ETF
VO
+$606M
2
LIN icon
Linde
LIN
+$434M
3
AXP icon
American Express
AXP
+$340M
4
CTAS icon
Cintas
CTAS
+$282M
5
DCUE
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
+$235M

Sector Composition

Rank Sector Weight
1 Financials 11.95%
2 Technology 11.56%
3 Healthcare 8.76%
4 Consumer Discretionary 6.63%
5 Industrials 6.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBCP icon
2976
Concrete Pumping Holdings
BBCP
$482M
$80.7K ﹤0.01%
12,045
-3,349
-22% -$25.7K
CTMX icon
2977
CytomX Therapeutics
CTMX
$736M
$80.2K ﹤0.01%
30,027
-6,323
-17% -$24.3K
CECO icon
2978
Ceco Environmental
CECO
$4.58B
$79.7K ﹤0.01%
14,518
-2,832
-16% -$16.5K
PLRX icon
2979
Pliant Therapeutics
PLRX
$67.5M
$79.2K ﹤0.01%
11,300
-2,197
-16% -$22.4K
RMO
2980
DELISTED
Romeo Power, Inc.
RMO
$78.2K ﹤0.01%
52,451
-16,340
-24% -$34.4K
GRTS
2981
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$77.2K ﹤0.01%
18,726
-3,531
-16% -$18.7K
STR
2982
DELISTED
Sitio Royalties
STR
$76.8K ﹤0.01%
+2,849
New +$64.2K
TXMD icon
2983
TherapeuticsMD
TXMD
$24.1M
$76.8K ﹤0.01%
4,042
– –
IMA
2984
ImageneBio Inc
IMA
$67M
$76.1K ﹤0.01%
1,040
-121
-10% -$12.9K
EAR
2985
DELISTED
Eargo, Inc. Common Stock
EAR
$75.9K ﹤0.01%
717
-146
-17% -$14.4K
TLMD
2986
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$75.5K ﹤0.01%
+25,243
New +$55.6K
ORIC icon
2987
Oric Pharmaceuticals
ORIC
$1.43B
$75.3K ﹤0.01%
14,105
-2,856
-17% -$25.7K
AGS
2988
DELISTED
PlayAGS
AGS
$74.8K ﹤0.01%
+11,216
New +$84.2K
EPZM
2989
DELISTED
Epizyme, Inc
EPZM
$74.6K ﹤0.01%
64,897
+12,981
+25% +$21.2K
PRTK
2990
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$73.9K ﹤0.01%
24,868
-3,368
-12% -$12.7K
TSHA icon
2991
Taysha Gene Therapies
TSHA
$1.99B
$73.2K ﹤0.01%
11,233
-1,731
-13% -$12.9K
LTRPA
2992
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$71.3K ﹤0.01%
34,783
+198
+0.6% +$420
DIDI
2993
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
$71.3K ﹤0.01%
+28,500
New +$112K
LXRX icon
2994
Lexicon Pharmaceuticals
LXRX
$1.06B
$70.5K ﹤0.01%
33,729
-5,611
-14% -$15.6K
DTIL icon
2995
Precision BioSciences
DTIL
$206M
$70.5K ﹤0.01%
763
-132
-15% -$17.9K
REKR icon
2996
Rekor Systems
REKR
$97.9M
$70.2K ﹤0.01%
15,396
-3,044
-17% -$14.3K
ZVRA icon
2997
Zevra Therapeutics
ZVRA
$670M
$70.1K ﹤0.01%
13,939
-3,825
-22% -$24.3K
RJET
2998
Republic Airways Holdings
RJET
$957M
$70.1K ﹤0.01%
1,062
-261
-20% -$18.7K
BNED icon
2999
Barnes & Noble Education
BNED
$425M
$69.7K ﹤0.01%
195
-36
-16% -$19.2K
CUE icon
3000
Cue Biopharma
CUE
$121M
$69.4K ﹤0.01%
474
-98
-17% -$20.8K
118 119
120
121 122

Similar funds

VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s Q1 2022 Portfolio in Review

As of Q1 2022, Manulife (Manufacturers Life Insurance) held 3,267 positions worth $153B, up 93,346% from $163M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Manulife (Manufacturers Life Insurance)'s Q1 2022 filing shows 155 new, 738 increased, 2,125 reduced and 210 closed positions. Its largest new stake was iShares MSCI Canada ETF: 3,413,430 shares worth $137M. The largest sale was Vanguard Morningstar Mid-Cap ETF, an estimated $606M.

By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

  • Manulife (Manufacturers Life Insurance)'s largest Q1 2022 buy was iShares MSCI Canada ETF: 3,413,430 shares worth $137M.
  • Manulife (Manufacturers Life Insurance) added most to Microsoft in Q1 2022, an estimated $322M increase.
  • Manulife (Manufacturers Life Insurance)'s biggest Q1 2022 reduction was Vanguard Morningstar Mid-Cap ETF, cutting an estimated $606M.
  • Manulife (Manufacturers Life Insurance) fully exited Dominion Energy, Inc. 2019 Series A Corporate Units in Q1 2022, selling an estimated $235M.
  • Manulife (Manufacturers Life Insurance)'s ten largest holdings make up 31% of its $153B portfolio in Q1 2022.
  • Manulife (Manufacturers Life Insurance) opened 155 new positions and closed 210 in Q1 2022.
  • Manulife (Manufacturers Life Insurance)'s portfolio value rose 93,346% quarter-over-quarter to $153B.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2022, filed 20 May 2022.